It is not approved by the FDA for the treatment, prevention, or diagnosis of any disease
Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus
When liraglutide (a closely related GLP-1 agonist) was administered for just two weeks, it reduced thromboxane-induced platelet aggregation by 54% (95% CI: 18%-90%, p = 0.003)
Or call 1860-500-2244 or mail us at [email protected] .
doi: 10.3389/fmed.2023.1200952 [DOI] [PMC free article] [PubMed] [Google Scholar] 33.Pengo MF, Soranna D, Giontella A, Perger E, Mattaliano P, Schwarz EI, Lombardi C, Bilo G, Zambon A, Steier J, et al
6) We can provide free samples if you have any interest in our products